MIR4695: A Potential Drug Target and Biomarker (G100616120)
MIR4695: A Potential Drug Target and Biomarker
MIR4695 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and function have made it an attractive target for researchers to investigate, and a number of studies have shown promise in using MIR4695 as a therapeutic agent.
MIR4695 is a microRNA (miRNA), a small non-coding RNA molecule that plays a critical role in post-transcriptional gene regulation. MiRNAs are made up of 20-22nt sequences and are typically targeted for degradation by microbeams, which results in a stable population of RNA levels. They have been shown to play a crucial role in regulating gene expression and have been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.
One of the key features of MIR4695 is its ability to interact with other proteins, particularly with the protein encoded by the miR4695 gene. This interaction between MIR4695 and its target protein has been shown to play a role in regulating cellular processes such as cell growth, apoptosis, and inflammation.
In addition to its potential as a drug target, MIR4695 has also been shown to be a valuable biomarker for several diseases. For example, MIR4695 has been shown to be downregulated in a variety of cancer types, including breast, ovarian, and prostate cancers. This suggests that MIR4695 may be a useful biomarker for cancer diagnosis and treatment.
Another potential application of MIR4695 is its use as a therapeutic agent. Studies have shown that MIR4695 can be effectively targeted to cancer cells and that it has the potential to inhibit the growth and metastasis of these cells. This suggests that MIR4695 may be an effective agent for the treatment of cancer.
In conclusion, MIR4695 is a promising drug target and biomarker for a variety of diseases. Its unique structure and function make it an attractive target for researchers to investigate, and its potential as a therapeutic agent is further demonstrated by its ability to interact with other proteins and its role as a biomarker for cancer. Further studies are needed to fully understand the potential of MIR4695 as a drug and to determine its utility as a biomarker.
Protein Name: MicroRNA 4695
More Common Targets
MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800
